###begin article-title 0
A novel role for the Aurora B kinase in epigenetic marking of silent chromatin in differentiated postmitotic cells
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This license does not permit commercial exploitation or the creation of derivative works without specific permission.
###end p 1
###begin p 2
Combinatorial modifications of the core histones have the potential to fine-tune the epigenetic regulation of chromatin states. The Aurora B kinase is responsible for generating the double histone H3 modification tri-methylated K9/phosphorylated S10 (H3K9me3/S10ph), which has been implicated in chromosome condensation during mitosis. In this study, we have identified a novel role for Aurora B in epigenetic marking of silent chromatin during cell differentiation. We find that phosphorylation of H3 S10 by Aurora B generates high levels of the double H3K9me3/S10ph modification in differentiated postmitotic cells and also results in delocalisation of HP1beta away from heterochromatin in terminally differentiated plasma cells. Microarray analysis of the H3K9me3/S10ph modification shows a striking increase in the modification across repressed genes during differentiation of mesenchymal stem cells. Our results provide evidence that the Aurora B kinase has a role in marking silent chromatin independently of the cell cycle and suggest that targeting of Aurora B-mediated phosphorylation of H3 S10 to repressed genes could be a mechanism for epigenetic silencing of gene expression.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 593 604 593 604 <xref ref-type="bibr" rid="b11">Heard, 2005</xref>
###xml 606 618 606 618 <xref ref-type="bibr" rid="b7">Dillon, 2006</xref>
###xml 997 1009 997 1009 <xref ref-type="bibr" rid="b36">Turner, 2007</xref>
Establishing specific gene expression programmes during cell differentiation requires controlled activation and silencing of large numbers of genes. Once these patterns of expression or repression have been set up, they must be kept in place to maintain the identity of the differentiating cell. Chromatin is known to play a key role in these processes. It can exert its effects both at the local level, with single nucleosomes modulating access of factors to promoters and enhancers, and on a more global level through large-scale condensation of megabase regions or even entire chromosomes (Heard, 2005; Dillon, 2006). Chromatin-mediated silencing of gene expression is strongly influenced by epigenetic modifications of the core histones, which include methylation and acetylation of lysine residues and phosphorylation of serine residues. These modifications can directly affect chromatin packaging as well as influence the binding of chromatin proteins and transcription factors (reviewed in Turner, 2007).
###end p 4
###begin p 5
###xml 902 907 902 907 <italic>et al</italic>
###xml 896 913 896 913 <xref ref-type="bibr" rid="b1">Araki <italic>et al</italic>, 1988</xref>
###xml 929 950 929 950 <xref ref-type="bibr" rid="b25">Olins and Olins, 2005</xref>
###xml 985 990 985 990 <italic>et al</italic>
###xml 977 996 977 996 <xref ref-type="bibr" rid="b9">Gilbert <italic>et al</italic>, 2003</xref>
###xml 1024 1029 1024 1029 <italic>et al</italic>
###xml 1016 1035 1016 1035 <xref ref-type="bibr" rid="b31">Schulze <italic>et al</italic>, 1984</xref>
The presence of epigenetic modifications can alter the structure of gene expression domains that include the gene and surrounding sequences, and when these modifications extend over larger regions, they facilitate packaging of the DNA into visibly condensed heterochromatin. Constitutive heterochromatin, which is present throughout the cell cycle, is relatively gene poor and enriched for repetitive satellite sequences. Facultative heterochromatin is quite different in that it is the result of a developmentally regulated condensation of gene-rich euchromatic regions, which are decondensed and transcriptionally active in some cell types. Some of the most dramatic examples of facultative heterochromatin are observed during the final stages of cell differentiation. Terminally differentiated cells that exhibit this type of widespread heterochromatinisation include rod photoreceptor cells (Araki et al, 1988), neutrophils (Olins and Olins, 2005), nucleated erythrocytes (Gilbert et al, 2003) and plasma cells (Schulze et al, 1984). It seems likely that formation of facultative heterochromatin during cell differentiation involves at least some of the silencing mechanisms that affect gene expression locally. This suggests that there may be a point during cell differentiation when these local gene-silencing events reach a critical mass that is sufficient to give rise to visibly condensed facultative heterochromatin.
###end p 5
###begin p 6
###xml 209 214 209 214 <italic>et al</italic>
###xml 199 220 199 220 <xref ref-type="bibr" rid="b3">Bannister <italic>et al</italic>, 2001</xref>
###xml 230 235 230 235 <italic>et al</italic>
###xml 222 241 222 241 <xref ref-type="bibr" rid="b23">Nielsen <italic>et al</italic>, 2001</xref>
###xml 254 259 254 259 <italic>et al</italic>
###xml 243 265 243 265 <xref ref-type="bibr" rid="b2">Ayyanathan <italic>et al</italic>, 2003</xref>
###xml 267 291 267 291 <xref ref-type="bibr" rid="b12">Hediger and Gasser, 2006</xref>
###xml 485 490 485 490 <italic>et al</italic>
###xml 477 496 477 496 <xref ref-type="bibr" rid="b17">Lachner <italic>et al</italic>, 2001</xref>
###xml 577 587 577 587 <italic>Drosophila</italic>
###xml 800 805 800 805 <italic>et al</italic>
###xml 792 811 792 811 <xref ref-type="bibr" rid="b23">Nielsen <italic>et al</italic>, 2001</xref>
###xml 819 824 819 824 <italic>et al</italic>
###xml 813 830 813 830 <xref ref-type="bibr" rid="b24">Ogawa <italic>et al</italic>, 2002</xref>
###xml 843 848 843 848 <italic>et al</italic>
###xml 832 854 832 854 <xref ref-type="bibr" rid="b2">Ayyanathan <italic>et al</italic>, 2003</xref>
###xml 1122 1127 1100 1105 <italic>et al</italic>
###xml 1117 1133 1095 1111 <xref ref-type="bibr" rid="b21">Minc <italic>et al</italic>, 1999</xref>
###xml 577 587 <span type="species:ncbi:7227">Drosophila</span>
Methylation of histone H3 lysine 9 (K9) has been shown to be involved in epigenetic silencing of euchromatic genes and also marks the constitutive heterochromatin that is found close to centromeres (Bannister et al, 2001; Nielsen et al, 2001; Ayyanathan et al, 2003; Hediger and Gasser, 2006). An important function of methylated H3K9 groups is to act as a recognition site for heterochromatin protein 1 (HP1), which binds to the methylated lysine via the chromodomain region (Lachner et al, 2001). HP1 was originally identified as a modifier of position effect variegation in Drosophila and has been shown to associate strongly with constitutive heterochromatin. There is also evidence that it is recruited directly to some gene promoters where it participates in transcriptional silencing (Nielsen et al, 2001; Ogawa et al, 2002; Ayyanathan et al, 2003). Three HP1 proteins have been identified in mammals (alpha, beta and gamma). HP1alpha is mainly associated with constitutive heterochromatin, HP1beta is present both on pericentric heterochromatin and euchromatin, whereas HP1gamma is predominantly euchromatic (Minc et al, 1999).
###end p 6
###begin p 7
###xml 310 315 304 309 <italic>et al</italic>
###xml 302 321 296 315 <xref ref-type="bibr" rid="b8">Fischle <italic>et al</italic>, 2005</xref>
###xml 330 335 324 329 <italic>et al</italic>
###xml 323 341 317 335 <xref ref-type="bibr" rid="b14">Hirota <italic>et al</italic>, 2005</xref>
###xml 671 676 665 670 <italic>et al</italic>
###xml 665 682 659 676 <xref ref-type="bibr" rid="b38">Vader <italic>et al</italic>, 2006</xref>
###xml 1302 1307 1296 1301 <italic>et al</italic>
###xml 1294 1313 1288 1307 <xref ref-type="bibr" rid="b13">Hendzel <italic>et al</italic>, 1997</xref>
###xml 1326 1331 1320 1325 <italic>et al</italic>
###xml 1315 1337 1309 1331 <xref ref-type="bibr" rid="b40">Van Hooser <italic>et al</italic>, 1998</xref>
###xml 1343 1348 1337 1342 <italic>et al</italic>
###xml 1339 1354 1333 1348 <xref ref-type="bibr" rid="b41">Wei <italic>et al</italic>, 1998</xref>
###xml 1434 1439 1428 1433 <italic>et al</italic>
###xml 1426 1445 1420 1439 <xref ref-type="bibr" rid="b8">Fischle <italic>et al</italic>, 2005</xref>
Binding of HP1 to H3K9 has been shown to be affected by the presence of a phosphate group at serine 10 (S10ph). Phosphorylation of H3 S10 during G2/M has been found to prevent HP1beta from binding to the adjacent H3K9me residue. As a result, HP1beta is released from chromatin at the onset of mitosis (Fischle et al, 2005; Hirota et al, 2005). The kinase responsible for S10 phosphorylation is the Aurora B kinase, a component of the chromosomal passenger complex, which modulates chromosome structure and segregation at mitosis by promoting HP1 displacement from the chromosomes, and chromosome alignment and attachment to the microtubules of the mitotic spindle (Vader et al, 2006). The other subunits of the complex, INCENP, Survivin and Borealin, are non-enzymatic and are involved in regulating and targeting Aurora B to its substrates. In non-transformed cells, Aurora B has, until now, been considered to be highly cell-cycle regulated and to be involved primarily in protein phosphorylation during mitosis. The double histone H3 tri-methylated K9/phosphorylated S10 (H3K9me3/S10ph) modification generated by Aurora B is known to be widely distributed on mitotic chromosomes, and inhibition of S10 phosphorylation has been shown to interfere with chromosome condensation during mitosis (Hendzel et al, 1997; Van Hooser et al, 1998; Wei et al, 1998). The double modification has been proposed to be a marker of M phase (Fischle et al, 2005), but it has not been shown previously to be involved in modulating chromatin structure outside mitosis.
###end p 7
###begin p 8
Here we show that in addition to its functions during mitosis, the Aurora B kinase mediates formation of the double H3K9me3/S10ph modification independently of the cell cycle during cell differentiation. In terminally differentiated postmitotic plasma cells, this results in displacement of HP1beta from facultative heterochromatin. We also use microarray analysis to demonstrate the presence of domains of H3K9me3/S10ph at silent genes in differentiated cells. Our results suggest that binary modifications can play an important role in modulating the effects of specific histone modifications at different stages of development.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
Experimental systems
###end title 10
###begin p 11
###xml 665 674 665 674 <xref ref-type="fig" rid="f1">Figure 1A</xref>
###xml 744 767 744 767 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S2</xref>
###xml 995 1004 995 1004 <xref ref-type="fig" rid="f1">Figure 1A</xref>
To identify epigenetic markers that are involved in long-term silencing of gene expression during cell differentiation, we initially screened facultative heterochromatin in terminally differentiated bone marrow plasma cells for the presence of candidate marks that might play a role in silencing. The results of this analysis revealed an unexpected correlation between the presence of visible heterochromatin and the binary K9me3/S10ph modification on histone H3. The double modification was detected by immunofluorescence (IF) using an antibody that specifically recognises these modifications when they are present in combination on the same histone H3 molecule (Figure 1A). The specificity of the antibody was confirmed by western blotting (Supplementary Figure S2), peptide ELISA and peptide competition, which showed that it did not crossreact with tri-methyl K9 (K9me3) alone, phospho-S10 (S10ph) alone, di-methyl K9/phospho-S10 (K9me2/S10ph) or tri-methyl K27/phospho-S28 (K27me3/S28ph) (Figure 1A). Analysis by IF using this antibody showed strong staining of facultative heterochromatin in 100% of bone marrow plasma cells. A particularly striking aspect of this result is the fact that plasma cells are postmitotic, whereas the double modification had previously been thought to be associated with the G2/M phase of the cell cycle and displacement of HP1 from mitotic chromosomes. This finding led us to perform a detailed analysis of the role of the double H3K9me3/S10ph modification in heterochromatin formation and epigenetic marking of silent genes during cell commitment and differentiation.
###end p 11
###begin p 12
###xml 156 171 156 171 <xref ref-type="fig" rid="f1">Figure 1B and C</xref>
###xml 340 348 340 348 <italic>in vitro</italic>
###xml 403 408 403 408 <italic>et al</italic>
###xml 398 414 398 414 <xref ref-type="bibr" rid="b32">Shea <italic>et al</italic>, 2003</xref>
###xml 533 538 533 538 <italic>et al</italic>
###xml 525 544 525 544 <xref ref-type="bibr" rid="b27">Peister <italic>et al</italic>, 2004</xref>
###xml 575 583 575 583 <italic>in vitro</italic>
###xml 661 684 661 684 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S1</xref>
###xml 935 940 935 940 <italic>et al</italic>
###xml 925 946 925 946 <xref ref-type="bibr" rid="b37">Underhill <italic>et al</italic>, 2003</xref>
###xml 953 961 953 961 <italic>in vitro</italic>
###xml 986 1009 986 1009 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S1</xref>
The model systems that were used for the analysis were differentiation of mesenchymal stem cells and terminal differentiation of B cells into plasma cells (Figure 1B and C). The multipotent mesenchymal stem cell line C3H10T1/2 can be induced to differentiate into osteocytes, chondrocytes and adipocytes and has been used extensively as an in vitro model for mesenchymal stem cell differentiation (Shea et al, 2003). In this study, the cells were differentiated into osteocytes by treatment with thyroxine and dexamethasone (Peister et al, 2004). Plasma cells were generated in vitro by differentiation of primary splenic B cells (see Materials and methods and Supplementary Figure S1). Terminal differentiation of B cells into plasma cells is accompanied by widespread gene silencing and formation of facultative heterochromatin as the cell becomes specialised for the production and secretion of large amounts of antibody (Underhill et al, 2003). The in vitro differentiation system (Supplementary Figure S1) offered the advantage of providing enough plasma cells for chromatin analysis.
###end p 12
###begin p 13
###xml 231 240 231 240 <xref ref-type="fig" rid="f1">Figure 1D</xref>
###xml 295 296 295 296 <sup>+</sup>
###xml 365 366 365 366 <sup>+</sup>
###xml 459 460 459 460 <sup>+</sup>
###xml 523 524 523 524 <sup>+</sup>
Because of the known link between the presence of the double modification and mitosis, the cell division status of the cells was determined before and after differentiation by measurement of bromodeoxyuridine (BrdU) incorporation (Figure 1D). The activated B cells were clearly cycling (75% BrdU+), whereas the plasma cells were almost entirely postmitotic (3% BrdU+). The undifferentiated C3H10T1/2 mesenchymal stem cells were also actively cycling (89% BrdU+) and became largely postmitotic after differentiation (8% BrdU+).
###end p 13
###begin title 14
The histone H3K9me3/S10ph double modification becomes enriched on chromatin of differentiated postmitotic cells
###end title 14
###begin p 15
###xml 489 498 489 498 <xref ref-type="fig" rid="f2">Figure 2A</xref>
###xml 694 703 694 703 <xref ref-type="fig" rid="f2">Figure 2D</xref>
###xml 798 803 798 803 <italic>et al</italic>
###xml 790 810 790 810 <xref ref-type="bibr" rid="b8">Fischle <italic>et al</italic> (2005)</xref>
###xml 1335 1344 1335 1344 <xref ref-type="fig" rid="f2">Figure 2A</xref>
The mesenchymal stem-cell and B-cell differentiation systems were used to analyse the distribution of the double modification before and after cell differentiation and exit from the cell cycle. Immunostaining was carried out using the anti-H3K9me3/S10ph antibody. Staining of the undifferentiated mesenchymal stem cells showed a strong punctate staining for the double modification in 23% of the cells. The punctuate staining coincided with the DAPI-dense pericentromeric heterochromatin (Figure 2A). The larger size of these cells identified them as being in G2 and this was confirmed by FACS analysis of the level of the double modification in cells that were gated according to DNA content (Figure 2D). The results of the immunostaining and FACS are in agreement with the observation by Fischle et al (2005) of a global increase in H3K9me3/S10ph that coincides with the onset of G2/M. The staining was much lower in the remaining cells and many of the cells showed little signal. The variation in the signal that was observed in the dull cells is likely to reflect progression through the different stages of the cell cycle. A quite different result was obtained when the cells were induced to differentiate along the osteogenic pathway. The differentiated postmitotic cells showed staining in the nuclei of all the cells analysed (Figure 2A). The staining in the differentiated cells was found at the pericentromeric heterochromatin and also as a more diffuse signal that appeared to extend over much of the rest of the chromatin.
###end p 15
###begin p 16
###xml 218 233 218 233 <xref ref-type="fig" rid="f2">Figure 2B and E</xref>
###xml 808 817 808 817 <xref ref-type="fig" rid="f2">Figure 2B</xref>
###xml 1180 1192 1180 1192 <xref ref-type="bibr" rid="b4">Calame, 2006</xref>
###xml 1275 1284 1275 1284 <xref ref-type="fig" rid="f1">Figure 1A</xref>
In the activated B-cell cultures, 27% of the cells showed a strong punctate staining for the double modification. Once again, the larger size of the positive cells and the FACS analysis identified them as being in G2 (Figure 2B and E). A smaller proportion (16%) showed an intermediate staining of the pericentromeric heterochromatin, but the majority of the cells (56%) were negative for the double modification. The differentiated plasma cells showed a very strong nuclear staining in approximately 60% of the cells, despite the fact that these cells were clearly postmitotic. In the positively staining cells, the signal for H3K9me3/S10ph was particularly intense on the large masses of DAPI-dense facultative heterochromatin, but was also present as a more diffuse staining on the rest of the chromatin (Figure 2B). The observation that around 40% of the cells were negative for the double modification could be related to the fact that these are short-lived plasma cells in which a proportion of the cells are likely to have chromatin that is already undergoing pre-apoptotic changes. It should be noted that bone marrow plasma cells, which have been shown to be long-lived (Calame, 2006), showed a strong staining for the double modification in all the cells analysed (Figure 1A).
###end p 16
###begin p 17
###xml 133 142 133 142 <xref ref-type="fig" rid="f2">Figure 2C</xref>
The staining pattern for H3K9me3/S10ph was compared with the pattern obtained using an antibody that was specific for H3K9me3 alone (Figure 2C). There was no difference in the level and distribution of the single modification between undifferentiated and differentiated mesenchymal stem cells. The differentiated plasma cells gave a lower H3K9me3 signal compared to activated B cells. This may reflect the very high levels of the double H3K9me3/S10ph modification that were observed in plasma cells.
###end p 17
###begin p 18
###xml 262 271 262 271 <xref ref-type="fig" rid="f3">Figure 3A</xref>
###xml 446 455 446 455 <xref ref-type="fig" rid="f3">Figure 3A</xref>
###xml 827 842 827 842 <xref ref-type="fig" rid="f3">Figure 3A and B</xref>
###xml 1002 1012 1002 1012 <xref ref-type="fig" rid="f2">Figures 2C</xref>
###xml 1017 1019 1017 1019 <xref ref-type="fig" rid="f3">3B</xref>
Analysis of the double and single modifications by western blotting gave results that broadly supported the conclusions from the immunostaining. In particular, the plasma cells showed a much higher global level of the double modification than activated B cells (Figure 3A). The modification was completely absent from resting B cells. Significant levels of the double modification were also present in differentiated postmitotic C3H10T1/2 cells (Figure 3A). The levels were somewhat lower than the level in undifferentiated cells, but this was likely to reflect the fact that these cells were cycling and therefore included significant numbers of G2/M cells. The levels of the single H3K9me3 and H3S10ph modifications detected by western blotting showed only small variations between differentiated and undifferentiated cells (Figure 3A and B). The lower level of the H3K9me3 single modification that was observed by immunostaining of plasma cells compared with the level measured by western blotting (Figures 2C and 3B) could be due to reduced accessibility of the modification to intracellular antibody staining, suggesting that it may be located within the heterochromatin mass.
###end p 18
###begin title 19
Aurora B kinase is responsible for generating the double histone H3K9me3/S10ph modification in non-cycling differentiated cells
###end title 19
###begin p 20
###xml 287 292 287 292 <italic>et al</italic>
###xml 279 298 279 298 <xref ref-type="bibr" rid="b8">Fischle <italic>et al</italic>, 2005</xref>
###xml 464 473 464 473 <xref ref-type="fig" rid="f4">Figure 4B</xref>
###xml 631 640 631 640 <xref ref-type="fig" rid="f2">Figure 2B</xref>
###xml 990 999 990 999 <xref ref-type="fig" rid="f4">Figure 4A</xref>
###xml 1268 1283 1268 1283 <xref ref-type="fig" rid="f4">Figure 4A and B</xref>
###xml 1383 1398 1383 1398 <xref ref-type="fig" rid="f4">Figure 4C and D</xref>
We next tested whether the histone H3K9me3/S10ph mark in plasma cells and differentiated mesenchymal stem cells correlates with the presence of the Aurora B kinase, which is known to be responsible for generating the phospho-S10 moiety of the double modification during mitosis (Fischle et al, 2005). Immunostaining of postmitotic plasma cells showed intense staining for Aurora B, which coincided with the large DAPI-dense regions of facultative heterochromatin (Figure 4B). More diffuse staining was also observed on the rest of the chromatin. This pattern correlates closely with the distribution of the H3K9me3/S10ph staining (Figure 2B). The proportion of plasma cells that stained positively for Aurora B (54%) was similar to the proportion that was positive for the double modification. Aurora B was also present in 100% of differentiated mesenchymal cells where it was concentrated into dot-like nuclear foci that did not coincide with constitutive pericentromeric heterochromatin (Figure 4A). Activated B cells and undifferentiated mesenchymal stem cells both gave a pattern of Aurora B staining that was similar to the H3K9me3/S10ph distribution with staining of the pericentromeric heterochromatin observed in the G2 cells and largely absent from G1 cells (Figure 4A and B). This distribution was confirmed by FACS analysis of the levels of Aurora B in G1 and G2/M cells (Figure 4C and D).
###end p 20
###begin p 21
###xml 129 138 129 138 <xref ref-type="fig" rid="f4">Figure 4E</xref>
###xml 380 389 380 389 <xref ref-type="fig" rid="f4">Figure 4E</xref>
Western blotting analysis also showed that Aurora B is present in postmitotic plasma cells and differentiated mesenchymal cells (Figure 4E). The analysis of undifferentiated mesenchymal stem cells was also carried out on cells that were sorted into G1 and G2/M populations and showed that the level of Aurora B is higher in differentiated cells than in undifferentiated G1 cells (Figure 4E). These results indicate that Aurora B persists in differentiated postmitotic cells and provide support for the idea that it is involved in the epigenetic regulation of cell differentiation.
###end p 21
###begin p 22
###xml 112 120 112 120 <italic>in vitro</italic>
###xml 231 236 231 236 <italic>et al</italic>
###xml 226 242 226 242 <xref ref-type="bibr" rid="b10">Hauf <italic>et al</italic>, 2003</xref>
###xml 385 394 385 394 <xref ref-type="fig" rid="f4">Figure 4F</xref>
To directly test whether Aurora B is responsible for generating the double modification during differentiation, in vitro-differentiated plasma cells were treated with hesperadin, which specifically inhibits Aurora B activity (Hauf et al, 2003). Inhibition of the kinase resulted in a drastic reduction in the amount of H3K9me3/S10ph modification that was observed by western blotting (Figure 4F). This leads us to conclude that phosphorylation of H3 S10 by Aurora B is responsible for increasing the level of double H3K9me3/S10ph modification in postmitotic plasma cells.
###end p 22
###begin title 23
###xml 55 59 55 56 <italic>&#946;</italic>
Phosphorylation of histone H3 S10 blocks binding of HP1beta to di- and tri-methylated K9
###end title 23
###begin p 24
###xml 449 454 449 454 <italic>et al</italic>
###xml 440 460 440 460 <xref ref-type="bibr" rid="b20">Mateescu <italic>et al</italic>, 2004</xref>
###xml 470 475 470 475 <italic>et al</italic>
###xml 462 481 462 481 <xref ref-type="bibr" rid="b8">Fischle <italic>et al</italic>, 2005</xref>
###xml 576 584 576 584 <italic>in vitro</italic>
###xml 852 861 843 852 <xref ref-type="fig" rid="f5">Figure 5A</xref>
The presence of phosphorylated S10 has the potential to affect binding of proteins that recognise the adjacent methylated K9. One possible candidate for such an effect is HP1. Phosphorylation of S10 has been shown to modulate the binding of HP1 proteins to methylated histone H3K9, although different effects have been reported and there have been conflicting results for binding of different HP1 family members to di- and tri-methyl H3K9 (Mateescu et al, 2004; Fischle et al, 2005). We used surface plasmon resonance (SPR) to examine the effect of S10 phosphorylation on the in vitro binding of HP1beta to di- and tri-methyl H3K9. The SPR assay made use of a recombinant 6 x His-HP1beta protein and H3 peptides containing covalent modifications. Phosphorylation of S10 markedly decreased the interaction of HP1beta with both K9me3 and K9me2 peptides (Figure 5A). This result supports the idea that S10 phosphorylation forms part of a binary switch that regulates binding of HP1beta to chromatin.
###end p 24
###begin title 25
###xml 33 37 33 34 <italic>&#946;</italic>
Aurora B-dependent release of HP1beta from heterochromatin in plasma cells
###end title 25
###begin p 26
###xml 105 112 105 112 <italic>in vivo</italic>
###xml 295 304 289 298 <xref ref-type="fig" rid="f5">Figure 5C</xref>
###xml 467 475 458 466 <italic>in vitro</italic>
###xml 807 816 792 801 <xref ref-type="fig" rid="f5">Figure 5D</xref>
###xml 1015 1024 994 1003 <xref ref-type="fig" rid="f3">Figure 3C</xref>
###xml 760 763 <span type="species:ncbi:10116">rat</span>
###xml 778 783 <span type="species:ncbi:10090">mouse</span>
We next set out to investigate whether the presence of the double H3K9me3/S10ph modification affects the in vivo binding of HP1beta to chromatin during cell differentiation. Immunostaining was used to determine whether HP1beta is associated with the facultative heterochromatin of plasma cells (Figure 5C). In activated B cells, HP1beta showed the expected localisation to pericentromeric heterochromatin clusters. However, when the immunostaining was carried out on in vitro-differentiated plasma cells, HP1beta was depleted from the heterochromatic regions and was present more abundantly in regions of the nucleus that stained less brightly with DAPI. The cytoplasmic HP1beta staining in plasma cells was mainly due to crossreactivity of the secondary anti-rat antibody with mouse immunoglobulins (Igs) (Figure 5D). Western blot analysis showed that HP1beta is still present in plasma cells, thereby excluding the possibility that the absence of heterochromatin staining is due to loss of HP1beta from the cell (Figure 3C).
###end p 26
###begin p 27
###xml 46 54 46 54 <italic>in vitro</italic>
###xml 126 133 126 133 <italic>in vivo</italic>
###xml 229 236 226 233 <italic>ex vivo</italic>
###xml 600 608 594 602 <italic>in vitro</italic>
###xml 741 750 732 741 <xref ref-type="fig" rid="f5">Figure 5C</xref>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
To test whether the results obtained with the in vitro-differentiated cells reflected the distribution of HP1 in plasma cells in vivo, we assessed HP1beta localisation in the nuclei of short- and long-lived plasma cells isolated ex vivo. The short-lived plasma cells were isolated from spleens of LPS-immunised mice and the long-lived plasma cells were obtained from the bone marrow of mice that had been immunised with ovalbumin (see Materials and methods). Interestingly, the two types of cells gave different results. The short-lived splenic plasma cells had a similar HP1beta distribution to the in vitro-differentiated cells, whereas in the long-lived bone marrow cells, the localisation of HP1beta to the heterochromatin was restored (Figure 5C). Analysis of the subnuclear localisation of HP1beta in differentiated C3H10T1/2 cells showed that it is not visibly delocalised from heterochromatin (data not shown). This can be explained by the lower levels of the double H3K9me3/S10ph modification in these cells compared with plasma cells.
###end p 27
###begin p 28
###xml 245 253 239 247 <italic>in vitro</italic>
###xml 395 404 386 395 <xref ref-type="fig" rid="f5">Figure 5E</xref>
To establish whether Aurora B activity is responsible for HP1beta release from heterochromatin in short-lived plasma cells, we analysed the effect of the Aurora B inhibitor hesperadin on HP1beta distribution in plasma cell nuclei. Incubation of in vitro-differentiated plasma cells with hesperadin for 1.5 h resulted in relocalisation of HP1beta to the heterochromatic foci in 29% of the cells (Figure 5E), compared with 1% of untreated cells. This result demonstrates that Aurora B is involved in modulating the interaction of HP1beta with chromatin outside mitosis. The comparison between different types of plasma cells also suggests that the binding of HP1beta to heterochromatin is part of a complex phenomenon, with other factors coming into play during the transition from short- to long-lived plasma cells.
###end p 28
###begin title 29
Domains of H3K9me3/S10ph form at repressed genes in differentiated cells
###end title 29
###begin p 30
###xml 475 483 475 483 <xref ref-type="fig" rid="f6">Figure 6</xref>
###xml 417 422 <span type="species:ncbi:10090">mouse</span>
The association of the double H3K9me3/S10ph modification with facultative heterochromatin in plasma cells suggests that it could be an epigenetic marker for gene silencing. To address this question directly, a custom oligonucleotide tiling microarray was used to analyse the modification at the level of individual genes and to relate it to transcriptional activity. The microarray covered a 2-Mb gene-rich region of mouse chromosome 3, with an average resolution of 100 bp (Figure 6). The 67 genes in the region have a variety of expression patterns ranging from ubiquitous to highly tissue specific. Expression of all of the genes was measured in C3H10T1/2 cells before and after differentiation by quantitative real-time PCR (data not shown).
###end p 30
###begin p 31
###xml 374 375 366 367 <sub>2</sub>
###xml 393 401 385 393 <xref ref-type="fig" rid="f6">Figure 6</xref>
###xml 466 467 458 459 <sub>2</sub>
###xml 731 740 723 732 <xref ref-type="fig" rid="f6">Figures 6</xref>
###xml 745 746 737 738 <xref ref-type="fig" rid="f7">7</xref>
###xml 899 908 891 900 <xref ref-type="fig" rid="f6">Figures 6</xref>
###xml 913 914 905 906 <xref ref-type="fig" rid="f7">7</xref>
Chromatin from undifferentiated and differentiated C3H10T1/2 cells was precipitated using the alpha-H3K9me3/S10ph and alpha-H3K9me3 antibodies and the DNA was hybridised to the microarray. Inspection of the pattern obtained for H3K9me3/S10ph revealed a strong enrichment for the double modification on repressed genes in differentiated cells (defined by average positive log2 IP/input ratio) (Figure 6, yellow shadowed domains). In contrast, a generally negative log2 ratio for K9me3/S10ph was found at transcriptionally active genes (purple shadowed domains). A striking feature of the pattern of enrichment of the double modification was that it appears to define domains that can extend across several adjacent repressed genes (Figures 6 and 7). The pattern is dependent on differentiation, as enrichment for H3K9me3/S10ph on repressed genes was not observed in undifferentiated C3H10T1/2 cells (Figures 6 and 7, light-blue trace).
###end p 31
###begin p 32
###xml 168 176 168 176 <xref ref-type="fig" rid="f6">Figure 6</xref>
###xml 317 325 317 325 <xref ref-type="fig" rid="f6">Figure 6</xref>
In contrast, the highest levels of the single H3K9me3 modification are observed in undifferentiated cells, with peaks of enrichment present on active and silent genes (Figure 6, light-green trace). When the cells were differentiated, it was no longer possible to detect significant levels of the single modification (Figure 6, dark-green trace) and this was mirrored by the increase in the level of the double modification. This result suggests that H3K9me3 becomes widely modified by the presence of S10ph during cell differentiation, with the double H3K9me3/S10ph modification forming domains across silent genes.
###end p 32
###begin p 33
###xml 356 379 356 379 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S3</xref>
Conventional chromatin immunoprecipitation (ChIP) using quantitative real-time PCR was also carried out on activated B and plasma cells and was compared with the results from undifferentiated and differentiated mesenchymal cells. The results show increased levels of the double modification at silent genes in plasma cells compared with activated B cells (Supplementary Figure S3). Taken together, the data from the microarray and the PCR-ChIP analysis indicate that the H3K9me3/S10ph modification becomes progressively enriched at repressed genes as cells differentiate and suggest that it forms part of a mechanism for epigenetic marking of silent chromatin in differentiated postmitotic cells.
###end p 33
###begin title 34
Discussion
###end title 34
###begin title 35
A novel function for the Aurora B kinase in differentiated postmitotic cells
###end title 35
###begin p 36
###xml 343 369 343 369 <xref ref-type="bibr" rid="b5">Carmena and Earnshaw, 2003</xref>
###xml 494 499 494 499 <italic>et al</italic>
###xml 487 505 487 505 <xref ref-type="bibr" rid="b35">Terada <italic>et al</italic>, 1998</xref>
###xml 746 751 746 751 <italic>et al</italic>
###xml 738 757 738 757 <xref ref-type="bibr" rid="b34">Tatsuka <italic>et al</italic>, 1998</xref>
The results of this study add a new dimension to the biology of the Aurora B kinase by showing that it can act as a regulator of the epigenetic status of differentiated postmitotic cells. Previous work had shown that Aurora B is tightly regulated in cycling cells and phosphorylates proteins that are critical for the transit through mitosis (Carmena and Earnshaw, 2003). Aurora B expression is upregulated during the transition from S to G2, peaks in G2/M and is minimal in interphase (Terada et al, 1998). The observation that deregulation of Aurora B expression is associated with uncontrolled cell division in many types of cancer has reinforced the perception that the Aurora B kinase is primarily involved in cell-cycle regulation (Tatsuka et al, 1998). However, our results provide evidence that Aurora B also has important functions in non-dividing cells.
###end p 36
###begin p 37
###xml 309 314 306 311 <italic>et al</italic>
###xml 301 320 298 317 <xref ref-type="bibr" rid="b8">Fischle <italic>et al</italic>, 2005</xref>
###xml 329 334 326 331 <italic>et al</italic>
###xml 322 340 319 337 <xref ref-type="bibr" rid="b14">Hirota <italic>et al</italic>, 2005</xref>
In dividing cells, Aurora B is known to be responsible for a transient peak of histone H3S10 phosphorylation, which generates the double H3K9me3/S10ph modification at the G2/M phase of the cell cycle. This leads to the release of HP1beta and to chromatin changes necessary for chromosome segregation (Fischle et al, 2005; Hirota et al, 2005). Our study demonstrates that the double H3K9me3/S10ph modification is not restricted to mitotic cells, but is also found at high levels in differentiated postmitotic cells and that its presence depends on the activity of Aurora B.
###end p 37
###begin p 38
###xml 821 848 821 848 <xref ref-type="bibr" rid="b16">Johansen and Johansen, 2006</xref>
A particularly striking feature of plasma cell differentiation is the formation of large clusters of facultative heterochromatin as the nucleus shrinks and the cell specialises to become an antibody factory. The double H3K9me3/S10ph modification is strongly associated with these heterochromatic regions. It is interesting that plasma cells show no detectable increase in the levels of H3K9me3 without the accompanying S10ph despite there being a substantial increase in the amount of heterochromatin in these cells compared with activated B cells. This suggests that the presence of S10ph modification has an important role in modulating the epigenetic marking of facultative heterochromatin by H3K9me3 during cell differentiation. Previous studies have implicated H3 S10 phosphorylation in gene activation (reviewed in Johansen and Johansen, 2006). Our results suggest that the combination of S10 phosphorylation with K9 methylation can reverse this effect and turn the modification into a silencing mark.
###end p 38
###begin title 39
The double histone H3K9me3/S10ph modification is a marker for gene silencing during differentiation
###end title 39
###begin p 40
###xml 414 415 414 415 <sub>2</sub>
Microarray and conventional ChIP analysis of the distribution of the double H3K9me3/S10ph modification revealed a developmentally regulated association of the modification with gene silencing. Differentiation of mesenchymal stem cells is accompanied by the formation of domains of enrichment for the double modification that can extend across several adjacent silent genes. There is a corresponding decrease in log2 ratios and in the number of enrichment peaks observed for the single H3K9me3 modification, which suggests that it is converted into the double modification by addition of the phosphate group at S10. The highest levels of the double modification were present in terminally differentiated plasma cells, as measured by IF, western blotting and ChIP of individual genes. These results suggest that the complexity of epigenetic regulation can be increased during cell differentiation, as the readout from single modifications is subject to progressive modulation by the addition of new modifications to the same histone molecule. One effect would be to influence the binding of chromatin proteins, either by creating new binding sites or by preventing proteins from binding to existing sites.
###end p 40
###begin title 41
Aurora B generates a binary methyl/phospho switch that modulates HP1 binding to chromatin during differentiation
###end title 41
###begin p 42
###xml 374 405 371 402 <xref ref-type="bibr" rid="b15">Jacobs and Khorasanizadeh, 2002</xref>
###xml 415 420 412 417 <italic>et al</italic>
###xml 407 426 404 423 <xref ref-type="bibr" rid="b22">Nielsen <italic>et al</italic>, 2002</xref>
###xml 490 495 487 492 <italic>et al</italic>
###xml 482 501 479 498 <xref ref-type="bibr" rid="b30">Schotta <italic>et al</italic>, 2002</xref>
###xml 703 728 700 725 <xref ref-type="bibr" rid="b18">Maison and Almouzni, 2004</xref>
###xml 730 754 727 751 <xref ref-type="bibr" rid="b12">Hediger and Gasser, 2006</xref>
###xml 311 324 <span type="species:ncbi:4896">fission yeast</span>
A key observation in this study is the finding that HP1beta is displaced from facultative heterochromatin in short-lived plasma cells and that this displacement is reversed by inhibition of Aurora B. HP1 is a major component of constitutive heterochromatin, which is conserved in a wide range of organisms from fission yeast through to mammals. It binds to methylated H3K9 (Jacobs and Khorasanizadeh, 2002; Nielsen et al, 2002) and recruits the Su(Var)39 histone methyltransferase (Schotta et al, 2002), thereby promoting further H3K9 methylation and reinforcing the process of heterochromatinisation. HP1 also recruits histone deacetylases, cohesin and the CAF1 chromatin assembly complex (reviewed in Maison and Almouzni, 2004; Hediger and Gasser, 2006).
###end p 42
###begin p 43
###xml 172 182 172 182 <italic>Drosophila</italic>
###xml 216 221 216 221 <italic>et al</italic>
###xml 205 227 205 227 <xref ref-type="bibr" rid="b28">Piacentini <italic>et al</italic>, 2003</xref>
###xml 300 310 300 310 <italic>Drosophila</italic>
###xml 325 330 325 330 <italic>et al</italic>
###xml 318 336 318 336 <xref ref-type="bibr" rid="b43">de Wit <italic>et al</italic>, 2007</xref>
###xml 453 458 453 458 <italic>et al</italic>
###xml 447 464 447 464 <xref ref-type="bibr" rid="b39">Vakoc <italic>et al</italic>, 2005</xref>
###xml 614 639 614 639 <italic>Schizosaccharomyces pombe</italic>
###xml 861 884 861 884 <xref ref-type="bibr" rid="b42">Zofall and Grewal, 2006</xref>
###xml 172 182 <span type="species:ncbi:7227">Drosophila</span>
###xml 300 310 <span type="species:ncbi:7227">Drosophila</span>
###xml 614 639 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
Although HP1 has been thought to be associated mainly with gene silencing, recent studies have shown that it is associated with transcriptionally active chromatin puffs on Drosophila polytene chromosomes (Piacentini et al, 2003) and that it binds within the transcribed regions of a number of active Drosophila genes (de Wit et al, 2007). Together with studies that have revealed the presence of methylated H3K9 within active transcription units (Vakoc et al, 2005), these results point to a dual role for HP1 in activating and silencing transcription. This conclusion has received further support from studies in Schizosaccharomyces pombe showing that Swi6/HP1 recruits the chromatin opening protein Epe1, which in turn makes heterochromatin more accessible to transcription by RNA polymerase II, a necessary precursor to RNAi-mediated heterochromatinisation (Zofall and Grewal, 2006). Displacement of HP1 from chromatin would, therefore, be expected to have complex effects on activation and silencing of transcription.
###end p 43
###begin p 44
###xml 539 544 539 544 <italic>et al</italic>
###xml 531 550 531 550 <xref ref-type="bibr" rid="b9">Gilbert <italic>et al</italic>, 2003</xref>
###xml 509 516 <span type="species:ncbi:9031">chicken</span>
###xml 586 593 <span type="species:ncbi:9031">chicken</span>
These results raise the possibility that displacement of HP1 could be important for long-term silencing of gene expression in differentiated cells. A second effect of displacing HP1 could be to allow binding of other, as yet, unidentified chromatin proteins that would recognise the double modification and would be involved in maintaining transcriptional silencing and formation of facultative heterochromatin. This idea is supported by the observation that HP1 is absent from facultative heterochromatin in chicken erythrocytes (Gilbert et al, 2003). However, the absence of HP1 from chicken erythrocyte heterochromatin appears to be due to complete loss of HP1 from the nucleus rather than a histone modification displacing HP1 from chromatin.
###end p 44
###begin p 45
Our data indicate that the single H3K9me3 modification is converted by the Aurora B kinase into a double H3K9me3/S10ph modification on a proportion of nucleosomes at repressed genes. The double H3K9me3/S10ph modification would also generate a novel binding site that has the potential to be recognised by other proteins that participate in the formation of a permanent repressive structure.
###end p 45
###begin p 46
A key requirement for generating the binary methyl/phospho switch in differentiated postmitotic cells is the uncoupling of Aurora B kinase regulation from the cell cycle. This is likely to involve association of the kinase with a different set of proteins as cells exit from the cell cycle. Identification of the factors that lead to this change in Aurora B function will be an important area of future research.
###end p 46
###begin title 47
Materials and methods
###end title 47
###begin title 48
Antibodies
###end title 48
###begin p 49
###xml 274 279 262 267 <italic>et al</italic>
###xml 269 285 257 273 <xref ref-type="bibr" rid="b6">Chow <italic>et al</italic>, 2005</xref>
###xml 375 378 <span type="species:ncbi:10116">rat</span>
###xml 415 420 <span type="species:ncbi:10090">mouse</span>
###xml 454 459 <span type="species:ncbi:10090">mouse</span>
###xml 602 608 <span type="species:ncbi:9986">rabbit</span>
###xml 732 738 <span type="species:ncbi:9986">rabbit</span>
###xml 743 754 <span type="species:ncbi:3704">horseradish</span>
###xml 804 810 <span type="species:ncbi:9986">rabbit</span>
The following antibodies were used in western blot analysis, ChIP and IF: alpha-histone H3 (Abcam ab1791), alpha-H4 (Upstate 07-108), alpha-H3K9me3/S10ph (Abcam ab5819) (peptide ELISA to confirm the specificity of this antibody was carried out as described previously; Chow et al, 2005), alpha-H3K9me3 (Upstate 07-442), alpha-Aurora B (Abcam ab2254), alpha-HP1beta (anti-M31 rat monoclonal MCA1946; Serotec), alpha-mouse IgM-Texas red (Vector) and alpha-mouse IgG-Texas red (vector), alpha-beta-tubulin (Santa Cruz Biotechnologies) and alpha-actin (Sigma). Control antibodies for ChIP were nonspecific rabbit IgG (Santa Cruz Biotechnologies) and alpha-FLAG antibody (Sigma). Secondary antibodies for western blot studies were alpha-rabbit IgG-horseradish peroxidase-conjugated antibody (Sigma) and alpha-rabbit IgG-alkaline phosphatase-conjugated antibody (Sigma).
###end p 49
###begin title 50
Cell cultures
###end title 50
###begin p 51
###xml 100 105 100 105 <italic>et al</italic>
###xml 89 111 89 111 <xref ref-type="bibr" rid="b29">Sabbattini <italic>et al</italic>, 2001</xref>
Resting B-cell isolation and B-cell activation were carried out as described previously (Sabbattini et al, 2001). The activated B cells were positively selected with biotinylated anti-CD19 antibody (BD Biosciences Pharmingen) conjugated to streptavidin beads (CELLection Dynabeads; Dynal) and released from the beads before further analysis.
###end p 51
###begin p 52
###xml 288 293 287 292 <italic>et al</italic>
###xml 280 300 279 299 <xref ref-type="bibr" rid="b27">Peister <italic>et al</italic> (2004)</xref>
C3H10T1/2 cells were expanded in complete expansion medium, DMEM medium supplemented with 10% FCS, 100 U/ml penicillin, 100 mug/ml streptomycin, 2 mM glutamax, 2 mM non-essential amino acids (Sigma) and 2 mM sodium pyruvate. Osteogenic differentiation was induced as described in Peister et al (2004) by culturing the C3H10T1/2 cells in IMDM supplemented with 10% FCS, 10% HS, 100 U/ml penicillin, 100 mug/ml streptomycin, 2 mM glutamax, 20 mM beta-glycerolphosphate, 50 ng/ml thyroxine, 1 nM dexamethasone and 0.5 muM ascorbic acid (all from Sigma) for 3 weeks. To confirm differentiation, an aliquot of the cells was fixed for 2 min with 1% formaldehyde and then stained for phosphatase activity using OPD (Dako) as a chromogenic substrate. Real-time PCR was used to confirm expression of the osteogenic markers alkaline phosphatase and osteocalcin. For BrdU incorporation studies, C3H10T1/2 cells were incubated in media with 10 muM BrdU for 2 h.
###end p 52
###begin title 53
###xml 0 8 0 8 <italic>In vitro</italic>
In vitro differentiation and selection of plasma cells
###end title 53
###begin p 54
###xml 909 910 893 894 <sup>+</sup>
###xml 984 985 964 965 <sup>+</sup>
###xml 995 996 975 976 <sup>&#8722;</sup>
###xml 1024 1031 1004 1011 <italic>ex vivo</italic>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 470 474 <span type="species:ncbi:9925">goat</span>
###xml 1050 1054 <span type="species:ncbi:10090">mice</span>
Spleens from 6- to 10-week-old CBAB6F1 mice were disaggregated and the single-cell suspension was centrifuged on a Ficoll cushion to remove erythrocytes and cultured for 7 days in RPMI supplemented with 15% FCS, 50 muM 2-mercaptoethanol, 50 mug/ml gentamicin, 25 mug/ml LPS, 5 ng/ml IL-5, 5 ng/ml IL-6 and 10 ng/ml IL-10. On day 7, the cells were again centrifuged on a Ficoll cushion to remove dead cells and the cells obtained from the interface were blocked with 10% goat serum and 5 mug/ml anti-FC receptor gamma III/II (BD Biosciences Pharmingen). The cells were then incubated with streptavidin beads (CELLection Dynabeads; Dynal) conjugated with biotinylated alpha-syndecan-1 antibody (BD Biosciences Pharmingen). Following magnetic selection, the cells were washed and released from the beads by digestion with DNaseI and incubated with alpha-B220-conjugated magnetic beads (Dynal) to deplete the B220+ cells. After selection, the cultures were typically >97% alpha-syndecan-1+/>98% B220-. For plasma cell isolation ex vivo from bone marrow, mice were immunised with ovalbumin, followed by a second immunisation after 3 weeks. Bone marrow was collected 3 days after the second immunisation. Plasma cells were isolated from spleen 7 days after immunisation with LPS. Plasma cell-enriched cell preparations from bone marrow and spleen were obtained by centrifugation on a Ficoll cushion followed by positive selection with alpha-syndecan-1 antibody conjugated to magnetic beads. For BrdU incorporation assays, activated B and plasma cells were incubated in media with 10 muM BrdU for 6 h.
###end p 54
###begin title 55
IF microscopy
###end title 55
###begin p 56
###xml 57 62 57 62 <italic>et al</italic>
###xml 53 68 53 68 <xref ref-type="bibr" rid="b19">Mak <italic>et al</italic>, 2002</xref>
###xml 143 149 <span type="species:ncbi:9986">rabbit</span>
###xml 169 172 <span type="species:ncbi:10116">rat</span>
IF analysis was carried out as described previously (Mak et al, 2002). Secondary antibodies used for fluorescent detection were Alexa 488 anti-rabbit and Alexa 488 anti-rat (both from Molecular Probes). Samples were mounted in Vectashield supplemented with DAPI (10 mug/ml) and images were collected by confocal microscopy using a TCS-SP1 microscope (Leica Microsystems) and Metamorph 4.0 software.
###end p 56
###begin title 57
ChIP
###end title 57
###begin p 58
###xml 118 123 118 123 <italic>et al</italic>
###xml 108 129 108 129 <xref ref-type="bibr" rid="b33">Szutorisz <italic>et al</italic>, 2005</xref>
###xml 198 208 198 208 <italic>Drosophila</italic>
###xml 284 289 284 289 <italic>et al</italic>
###xml 276 295 276 295 <xref ref-type="bibr" rid="b26">O'Neill <italic>et al</italic>, 2006</xref>
###xml 198 208 <span type="species:ncbi:7227">Drosophila</span>
###xml 546 552 <span type="species:ncbi:9986">rabbit</span>
ChIP analysis of unfixed chromatin or formaldehyde-fixed chromatin was carried out as described previously (Szutorisz et al, 2005). For plasma cells, the ChIP was carried out in the presence of SL2 Drosophila cells according to the carrier ChIP protocol described previously (O'Neill et al, 2006). Unfixed chromatin (150 mug) was immunoprecipitated with the following antibodies: 20 mul of anti-diacetylated histone H3 (Upstate 06-599), 100 mul alpha-H3K9me3/S10ph (Abcam ab5819), 20 mul alpha-H3K9me3 (Upstate) and as control 37 mul nonspecific rabbit IgG (Santa Cruz Biotechnology). For the fixed chromatin method, 500 mug of fixed chromatin was immunoprecipitated and the same ratio of chromatin to antibody was used that was described for the unfixed chromatin procedure. The input and immunoprecipitated samples were phenol/chloroform-extracted and resuspended in 100 mul of TE. For quantitation, 2 mul of the input and the immunoprecipitated DNA (IP) samples were amplified by real-time PCR using SYBR-green mix (Bio-Rad) and a DNA Engine Opticon system (MJ Research Inc.). PCRs were carried out in duplicate. Primer sequences can be obtained on request.
###end p 58
###begin title 59
Microarray analysis
###end title 59
###begin p 60
###xml 701 702 700 701 <sub>2</sub>
###xml 1262 1263 1261 1262 <sub>2</sub>
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
Microarrays were generated by NimbleGen Systems by tiling 50-bp oligonucleotides across a region of 2 Mb of mouse chromosome 13 (Chr3: 87462375-89534891) with 100-bp resolution. High-frequency repeats were excluded by repeat masking. DNA (4 mug) from immunoprecipitation and input was amplified using the GenomePlex WGA kit (Sigma). After amplification, the DNA was tested for enrichment at control loci and compared to the unamplified DNA by real-time PCR. The amplified input and pull-down DNA were labelled with Cy3 and Cy5 by random priming and hybridised to the microarray by NimbleGen. Two immunoprecipitations were performed for each antibody. Input and pull-down signal intensities, scaled log2 ratios and enrichment peaks were provided by NimbleGen. Enrichment peaks were calculated using a permutation-based algorithm (see NimbleScan User's Guide at , default algorithm). This estimates the false discovery rate (FDR) for each peak, which is equal to the probability of finding a peak of comparable significance by chance. Significant peaks are characterised by low FDRs and correspond to four or more probes within a 500-bp sliding window with signals above the cutoff value (cutoff values are a percentage ranging from 90 to 15% of a hypothetical log2 ratio maximum, which is the mean+6(standard deviation)).
###end p 60
###begin title 61
###xml 0 8 0 8 <italic>In vitro</italic>
In vitro binding analysis by SPR
###end title 61
###begin p 62
The assays were performed on a Biacore X instrument (Biacore, Milton Keynes, UK) with Biacore HBS-EP buffer (10 mM Hepes pH 7.4, 0.15 M NaCl, 3 mM EDTA, 0.005% Tween 20) at a flow rate of 10 mul/min. Anti-6 x His monoclonal antibody (Abcam; 6500 response units, RUs) and control anti-RNA polII monoclonal antibody (kind gift of Laszlo Tora; 6700 RU) were immobilised using the Amine Coupling Kit (Biacore) on flow cells 1 and 2, respectively, of a CM5 sensor chip. 6 x His-HP1beta (300 nM) was injected simultaneously over flow channels 1 and 2 followed by injection over both flow channels of 50 muM solutions of peptides for 2 min. After the injection, the dissociation of the complex was followed for 180 s. Non-phosphorylated peptides were also injected at lower concentrations for comparability to phosphorylated peptide binding. The difference between the increase in RU between flow channels 1 and 2 was used to measure the specific binding of the peptides to His-HP1beta. At least two injections were carried out for each peptide. Data were analysed using Bioevaluation 3.2 software (Biacore).
###end p 62
###begin title 63
FACS sorting of G1 and G2/M cells
###end title 63
###begin p 64
###xml 69 70 69 70 <sup>7</sup>
###xml 115 116 109 110 <sub>2</sub>
Live logarithmically growing undifferentiated C3H10T1/2 cells (2 x 107) were stained for 30 min at 37degreesC/5% CO2 with the DNA-intercalating dye Hoechst 33342 (10 mug/ml). The cells were sorted by FACS into G1 and G2/M fractions on the basis of DNA content. Sorting was carried out with a FACS Vantage SE sorter (Becton Dickinson).
###end p 64
###begin title 65
Supplementary Material
###end title 65
###begin p 66
Supplementary Information
###end p 66
###begin p 67
We are grateful to Thomas Jenuwein for providing antibodies and to Laszlo Tora for the generous gift of hesperadin. We thank Henrietta Szutorisz for helpful comments on the manuscript. This work was supported by the Medical Research Council, UK. CC was supported by a Gordon Piller studentship from the Leukaemia Research Fund, SN was supported by European Community RTN (HPRN-CT 00504228) and HWA was supported by a fellowship from the Kay Kendall Leukaemia Fund.
###end p 67
###begin article-title 68
###xml 91 94 <span type="species:ncbi:10116">rat</span>
Histochemical observations on unique rod-like cells in the developing retina of the normal rat.
###end article-title 68
###begin article-title 69
Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation.
###end article-title 69
###begin article-title 70
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.
###end article-title 70
###begin article-title 71
Transcription factors that regulate memory in humoral responses.
###end article-title 71
###begin article-title 72
The cellular geography of Aurora kinases.
###end article-title 72
###begin article-title 73
Variant histone H3.3 marks promoters of transcriptionally active genes during mammalian cell division.
###end article-title 73
###begin article-title 74
High-resolution mapping reveals links of HP1 with active and inactive chromatin components.
###end article-title 74
###begin article-title 75
Gene regulation and large-scale chromatin organization in the nucleus.
###end article-title 75
###begin article-title 76
Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation.
###end article-title 76
###begin article-title 77
Formation of facultative heterochromatin in the absence of HP1.
###end article-title 77
###begin article-title 78
The small molecule hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint.
###end article-title 78
###begin article-title 79
Delving into the diversity of facultative heterochromatin: the epigenetics of the inactive X chromosome.
###end article-title 79
###begin article-title 80
Heterochromatin protein 1: don't judge the book by its cover!.
###end article-title 80
###begin article-title 81
Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation.
###end article-title 81
###begin article-title 82
Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin.
###end article-title 82
###begin article-title 83
Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail.
###end article-title 83
###begin article-title 84
Regulation of chromatin structure by histone H3S10 phosphorylation.
###end article-title 84
###begin article-title 85
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins.
###end article-title 85
###begin article-title 86
HP1 and the dynamics of heterochromatin maintenance.
###end article-title 86
###begin article-title 87
Mitotically stable association of polycomb group proteins eed and enx1 with the inactive x chromosome in trophoblast stem cells.
###end article-title 87
###begin article-title 88
Tethering of HP1 proteins to chromatin is relieved by phosphoacetylation of histone H3.
###end article-title 88
###begin article-title 89
Localization and phosphorylation of HP1 proteins during the cell cycle in mammalian cells.
###end article-title 89
###begin article-title 90
Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9.
###end article-title 90
###begin article-title 91
Rb targets histone H3 methylation and HP1 to promoters.
###end article-title 91
###begin article-title 92
A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells.
###end article-title 92
###begin article-title 93
Granulocyte heterochromatin: defining the epigenome.
###end article-title 93
###begin article-title 94
Epigenetic characterization of the early embryo with a chromatin immunoprecipitation protocol applicable to small cell populations.
###end article-title 94
###begin article-title 95
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential.
###end article-title 95
###begin article-title 96
###xml 78 88 78 88 <italic>Drosophila</italic>
###xml 78 88 <span type="species:ncbi:7227">Drosophila</span>
Heterochromatin protein 1 (HP1) is associated with induced gene expression in Drosophila euchromatin.
###end article-title 96
###begin article-title 97
Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation.
###end article-title 97
###begin article-title 98
###xml 16 26 16 26 <italic>Drosophila</italic>
###xml 16 26 <span type="species:ncbi:7227">Drosophila</span>
Central role of Drosophila SU(VAR)3-9 in histone H3-K9 methylation and heterochromatic gene silencing.
###end article-title 98
###begin article-title 99
###xml 60 68 <span type="species:ncbi:9606">patients</span>
Heterochromatin and nucleolus organizer regions in cells of patients with malignant and premalignant lymphatic diseases.
###end article-title 99
###begin article-title 100
BMP treatment of C3H10T1/2 mesenchymal stem cells induces both chondrogenesis and osteogenesis.
###end article-title 100
###begin article-title 101
Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage.
###end article-title 101
###begin article-title 102
###xml 136 141 <span type="species:ncbi:9606">human</span>
Multinuclearity and increased ploidy caused by overexpression of the Aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells.
###end article-title 102
###begin article-title 103
AIM-1: a mammalian midbody-associated protein required for cytokinesis.
###end article-title 103
###begin article-title 104
Defining an epigenetic code.
###end article-title 104
###begin article-title 105
Gene expression profiling reveals a highly specialized genetic program of plasma cells.
###end article-title 105
###begin article-title 106
The chromosomal passenger complex: guiding Aurora-B through mitosis.
###end article-title 106
###begin article-title 107
Histone H3 lysine 9 methylation and HP1 gamma are associated with transcription elongation through mammalian chromatin.
###end article-title 107
###begin article-title 108
Histone H3 phosphorylation is required for the initiation, but not maintenance, of mammalian chromosome condensation.
###end article-title 108
###begin article-title 109
Phosphorylation of histone H3 at serine 10 is correlated with chromosome condensation during mitosis and meiosis in Tetrahymena.
###end article-title 109
###begin article-title 110
Swi6/HP1 recruits a JmjC domain protein to facilitate transcription of heterochromatic repeats.
###end article-title 110
###begin p 111
###xml 61 62 61 62 <bold>A</bold>
###xml 877 878 868 869 <bold>B</bold>
###xml 1252 1253 1243 1244 <bold>C</bold>
###xml 1340 1341 1331 1332 <bold>D</bold>
Increased levels of H3K9me3/S10ph in plasma cell chromatin. (A) Immunofluorescence (IF) analysis of the distribution of H3K9me3/S10ph in bone marrow plasma cells (PC). Plasma cells (indicated by arrows) were identified by high levels of cytoplasmic immunoglobulins (Igs). Scale bar=10 mum. Histograms represent a peptide ELISA assay showing that the alpha-H3K9me3/S10ph antibody has high affinity for a peptide spanning aa 5-13 of histone H3 containing K9me3 and S10ph (1) and has negligible crossreactivity with peptides of the same region with either K9me3 alone (2) or K9me2/S10ph (3) or a peptide corresponding to aa 24-33 of H3 containing K27me3/S28ph (4). Western blotting with the alpha-H3K9me3/S10ph antibody shows that a peptide corresponding to aa 5-13 of histone H3 containing S10ph alone does not compete for binding to the epitope in a peptide competition assay. (B) Scheme showing the stages of B-cell development. Rearrangement of heavy- and light-chain Ig genes at the pro- and pre-B-cell stages gives rise to resting B cells, which are activated by encounter with antigen and differentiate into postmitotic antibody-secreting plasma cells. ProB, preB=progenitor and precursor B cells; rest B=resting B cells; act B=activated B cells. (C) Cell lineages originating from differentiation of C3H10T1/2 mesenchymal stem cells. (D) Bromodeoxyuridine (BrdU) incorporation in activated B cells, plasma cells and mesenchymal cells. The cells were incubated in medium with 10 muM BrdU. Incorporation of BrdU was measured by staining with FITC-conjugated alpha-BrdU antibody (Beckton and Dickinson) and FACS analysis. Staining for BrdU in the cell populations (black) is compared to background levels of autofluorescence in unstained cells (blue).
###end p 111
###begin p 112
###xml 92 93 92 93 <bold>A</bold>
###xml 189 190 189 190 <bold>B</bold>
###xml 271 279 271 279 <italic>in vitro</italic>
###xml 341 342 341 342 <bold>C</bold>
###xml 412 413 412 413 <bold>D</bold>
###xml 415 416 415 416 <bold>E</bold>
Distribution of the histone H3K9me3/S10ph double modification during cell differentiation. (A) H3K9me3/S10ph staining before and after differentiation of C3H10T1/2 mesenchymal stem cells. (B) H3 me3K9/pS10 staining in activated B cells and in plasma cells differentiated in vitro from splenic B cells. Plasma cells are indicated by arrows. (C) Staining for H3K9me3 in mesenchymal, activated B and plasma cells. (D, E) FACS analysis was used to show that the brightly stained cells observed by immunofluorescent staining were predominantly G2/M. Cells were gated into G1 and G2/M populations by propidium iodide (PI) staining for DNA content, and staining with alpha-H3K9me3/S10ph was measured in these populations.
###end p 112
###begin p 113
###xml 272 273 272 273 <bold>A</bold>
###xml 318 319 310 311 <bold>B</bold>
###xml 401 402 389 390 <bold>C</bold>
Global levels of H3K9me3/S10ph following cell differentiation. Western blotting of acid extracts from nuclei of resting B cells (rest B), activated B cells (act B), plasma cells (PC) and undifferentiated (C3H undiff) and differentiated (C3H diff) mesenchymal cells using (A) alpha-H3K9me3/S10ph and alpha-H3S10ph and (B) alpha-H3K9me3. The levels of histone H4 and H3 were used as a loading control. (C) Whole-cell extracts from purified resting B, activated B and plasma cells were analysed by western blotting using an alpha-HP1beta antibody. The Coomassie-stained gel and western blots for beta-tubulin and beta-actin are shown as loading controls.
###end p 113
###begin p 114
###xml 181 182 181 182 <bold>A</bold>
###xml 266 267 266 267 <bold>B</bold>
###xml 324 325 324 325 <bold>C</bold>
###xml 327 328 327 328 <bold>D</bold>
###xml 497 505 497 505 <xref ref-type="fig" rid="f2">Figure 2</xref>
###xml 554 555 550 551 <bold>E</bold>
###xml 936 937 928 929 <bold>F</bold>
Aurora B persists in the nucleus following differentiation and its kinase activity is required for generation of the double H3K9me3/S10ph mark in differentiated postmitotic cells. (A) Distribution of Aurora B in undifferentiated and differentiated C3H10T1/2 cells. (B) Staining of Aurora B in activated B and plasma cells. (C, D) FACS analysis was used to show that the brightly stained cells observed by immunofluorescent staining were predominantly G2/M. Cells were gated into G1 and G2/M as in Figure 2 and staining with alpha-Aurora B was measured. (E) Whole-cell extracts from purified resting B, activated B and plasma cells and undifferentiated and differentiated C3H10T1/2 cells were analysed by western blotting using an alpha-Aurora B antibody. Aurora B levels were also measured in undifferentiated C3H10T1/2 cells that had been FACS sorted into G1 and G2/M populations (right panel; see Materials and methods for details). (F) Western blot with alpha-H3K9me3/S10ph of acid-extracted proteins from plasma cells cultured for 1 h with 200 nM Aurora B inhibitor hesperadin or in medium alone.
###end p 114
###begin p 115
###xml 65 66 62 63 <bold>A</bold>
###xml 419 420 406 407 <bold>B</bold>
###xml 527 528 511 512 <bold>C</bold>
###xml 697 705 678 686 <italic>in vitro</italic>
###xml 707 715 688 696 <italic>in vitro</italic>
###xml 861 862 842 843 <bold>D</bold>
###xml 1045 1046 1022 1023 <bold>E</bold>
###xml 763 767 <span type="species:ncbi:10090">mice</span>
###xml 837 841 <span type="species:ncbi:10090">mice</span>
###xml 914 917 <span type="species:ncbi:10116">rat</span>
###xml 980 985 <span type="species:ncbi:10090">mouse</span>
HP1beta is relocated away from heterochromatin in plasma cells. (A) Surface plasmon resonance (SPR) analysis of binding of His-HP1beta to peptides corresponding to aa 1-15 of histone H3 with the indicated modifications. Peptides (50 muM) were injected over His-HP1beta immobilised on a Biacore flow cell. The presence of phosphorylated S10 reduces the affinity of HP1beta for peptides containing both K9me3 and K9me2. (B) Nonspecific binding of the peptides to the chip when injected over a flow cell control lacking HP1beta. (C) Distribution of HP1beta relative to DAPI-intense regions in activated B and plasma cells. The analysis was carried out on plasma cells that were either differentiated in vitro (in vitro PC), isolated from the spleen of LPS-immunised mice (splenic PC) or isolated from the bone marrow of ovalbumin-immunised mice (bone marrow PC). (D) Staining of plasma cells with the Alexa 488 alpha-rat secondary antibody alone showed some crossreactivity with the mouse immunoglobulin (Ig) in the cytoplasm but not the nucleus. (E) Incubation of plasma cells in a medium containing 200 nM hesperadin for 1.5 h results in relocalisation of HP1beta to heterochromatin (indicated by arrows) in 29% of the cells.
###end p 115
###begin p 116
###xml 543 544 543 544 <sub>2</sub>
###xml 624 625 624 625 <sub>2</sub>
###xml 717 718 717 718 <sub>2</sub>
###xml 1485 1508 1485 1508 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S4</xref>
###xml 164 169 <span type="species:ncbi:10090">mouse</span>
ChIP-on-chip analysis shows enrichment for H3K9me3/S10ph on repressed gene domains in differentiated C3H10T1/2 cells. The tiling microarray covers a 2-Mb region of mouse chromosome 3 containing 67 genes with different expression patterns (yellow=silent gene; purple=active gene). All the genes coloured in yellow are silent in both undifferentiated and differentiated cells with the exception of nestin, which is expressed in mesenchymal stem cells and silenced during differentiation. Domains of H3K9me3/S10ph enrichment, corresponding to log2 ratios above 0, are shadowed in yellow while domains of depletion (negative log2 ratios) are shadowed in purple. Data are represented in the upper tracing as the scaled log2 ratio (pull-down/input) of the hybridisation signal for DNA immunoprecipitated using the indicated antibody (dark-blue tracing=H3K9me3/S10ph in differentiated C3H10T1/2; light-blue tracing=H3K9me3/S10ph in undifferentiated C3H10T1/2; dark green=H3K9me3 in differentiated C3H10T1/2; light green=H3K9me3 in undifferentiated C3H10T1/2). The distribution of peaks of enrichment is shown in the panel below each tracing. The peaks are color-coded (red=high probability peak, false discovery rate (FDR)0.05; yellow=intermediate probability peak, FDR>0.1 and 0.2; grey=low probability peak, FDR>0.2) and were obtained using the NimbleGen default algorithm described in Materials and methods and in . Validation of the microarray analysis by real-time PCR is described in Supplementary Figure S4.
###end p 116
###begin p 117
Close-up view of the repressed gene domains within the 2-Mb region. Horizontal arrows indicate the direction of transcription (yellow=silent gene; purple=active gene).
###end p 117

